Large-scale testing (Phase 3)Ended earlyNCT00940095What this trial is testingClazosentan in Aneurysmal Subarachnoid HemorrhageWho this might be right forAneurysmal Subarachnoid Hemorrhage Idorsia Pharmaceuticals Ltd. 577
Not applicableLooking for participantsNCT06525012What this trial is testingObservational Study on Mortality and Outcome of Patients Hospitalized for Subarachnoid Hemorrhage of Aneurysmal Origin in Martinique Between 2013 and 2021Who this might be right forSubarachnoid Hemorrhage of Aneurysmal Cause University Hospital Center of Martinique 122
Large-scale testing (Phase 3)Study completedNCT03585270What this trial is testingClinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the BrainWho this might be right forAneurysmal Subarachnoid Hemorrhage Idorsia Pharmaceuticals Ltd. 409
Large-scale testing (Phase 3)Study completedNCT01258257What this trial is testingEARLYdrain - Outcome After Early Lumbar CSF-drainage in Aneurysmal SAHWho this might be right forAneurysmal Subarachnoid Hemorrhage Charite University, Berlin, Germany 300
Not applicableUnknownNCT03822260What this trial is testingEvaluation of Neuroinflamation of SAHWho this might be right forSubarachnoid Hemorrhage, Aneurysmal Bezmialem Vakif University 54
Large-scale testing (Phase 3)Study completedNCT00558311What this trial is testingClazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical ClippingWho this might be right forAneurysmal Subarachnoid Hemorrhage Idorsia Pharmaceuticals Ltd. 1,157